Texas Instruments forecasts Q1 revenue above estimates on strong chip demand

FAN Editor
A Texas Instruments Office is shown in San Diego, California
FILE PHOTO: A Texas Instruments Office is shown in San Diego, California, U.S., April 24, 2018. REUTERS/Mike Blake

January 25, 2022

(Reuters) -Texas Instruments Inc forecast current-quarter revenue above Wall Street estimates on Tuesday, betting on strong demand for its chips used in cars, smartphones and laptops, sending its shares up 6% in extended trading.

As demand for electronics including smartphones and consumer gadgets has risen faster than expected during the pandemic, semiconductor makers have doubled down on production, even as COVID-19 has hampered general operations and logistics.

Texas Instruments analog and embedded processing chips are used in a range of products that cater to a broad market, lowering the risk from dependence on a single customer segment.

The company said it expects first-quarter revenue between $4.5 billion and $4.9 billion. Analysts on average estimate revenue of $4.37 billion, according to IBES data from Refinitiv.

Texas Instruments fourth-quarter revenue rose 19% to $4.83 billion, topping analysts’ expectations of $4.43 billion, driven by strong demand in industrial and automotive markets.

Net income rose to $2.14 billion, or $2.27 per share, during the quarter ended Dec. 31, compared with $1.69 billion, or $1.80 per share, a year earlier.

Earlier this month, Taiwanese chip firm TSMC forecast multi-year growth on booming semiconductor demand and said it expects to lift capital spending to between $40 billion and $44 billion this year, compared with $30 billion it spent last year.

(Reporting by Yuvraj Malik, Tiyashi Datta and Amruta Khandekar in Bengaluru; Editing by Vinay Dwivedi)

Free America Network Articles

Leave a Reply

Next Post

Drugmaker Teva fueled opioid addiction in New York, jury finds

FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/ January 25, 2022 (This Dec. 30 story refiles to add dropped words “members of” in last paragraph) By Brendan Pierson NEW YORK (Reuters) – Teva Pharmaceutical Industries Ltd fueled opioid addiction […]